Skip to main content
. Author manuscript; available in PMC: 2021 Sep 9.
Published in final edited form as: Psychooncology. 2019 Jun 6;28(7):1544–1550. doi: 10.1002/pon.5130

Table 1.

Sample characteristics (N = 238)

N (%)
Age at survey, yearsa 32.7 (5.7)
Race
 White 188 (79.3)
 Black 9 (3.8)
 Asian 13 (5.5)
 Other 27 (11.4)
Ethnicity
 Hispanic/Latino 20 (8.4)
 Not Hispanic/Latino 217 (91.6)
Relationship status
 Partnered 135 (57.0)
 Not Partnered 102 (43.0)
Education
 College graduate 200 (84.4)
 Did not graduate from college 37 (15.6)
Income
 ≤$50,000 74 (31.2)
 >$50,000 117 (49.4)
 Decline to answer 46 (19.4)
 BMIa 25.9 (6.9)
Has biological child(ren) 67 (28.2)
Desires child(ren) 171 (71.9)
Cancer characteristics and treatment
 Cancer type
  Breast 66 (27.9)
  Lymphoma 62 (26.1)
  Gynecologic (cervix/uterus/ovary) 19 (8.0)
  Blood/leukemia 19 (8.0)
  Thyroid 14 (5.9)
  Other 57 (24.1)
 Cancer stage
  High Risk 3 (1.3)
  Standard Risk 2 (0.8)
  Low Risk 1 (0.4)
  I 48 (20.3)
  II 74 (31.2)
  III 40 (16.9)
  IV 18 (7.6)
  Unknown 51 (21.5)
 Age at diagnosis, yearsa 27.1 (7.1)
  < 15 12 (5.0)
  15–39 223 (93.7)
  40–44 3 (1.3)
 Time since diagnosis, yearsa 5.5 (4.7)
 Surgery 145 (61.2)
 Chemotherapy 187 (78.9)
 Radiation 117 (49.4)
 Endocrine therapy 43 (18.1)
 Bone marrow or stem cell transplant 14 (5.9)
 Unknown 1 (0.4)

Note. Due to missing data, some variables do not add up to 238.

a

Mean (Standard Deviation)